Susanne M. Bailer
Stuttgart, BW 70569, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1.
Journal: Molecular therapy. Oncology
Published: February 03, 2023
An AZT Analog with Strongly Pairing Ethynylpyridone Nucleobase and Its Antiviral Activity against HSV1.
Journal: Chemistry & biodiversity
Published: November 18, 2020
Patterns of Autologous and Nonautologous Interactions Between Core Nuclear Egress Complex (NEC) Proteins of α-, β- and γ-Herpesviruses.
Journal: Viruses
Published: February 14, 2020
Cold atmospheric plasma as antiviral therapy - effect on human herpes simplex virus type 1.
Journal: The Journal of general virology
Published: January 22, 2020
Comprehensive analysis of nuclear export of herpes simplex virus type 1 tegument proteins and their Epstein-Barr virus orthologs.
Journal: Traffic (Copenhagen, Denmark)
Published: May 20, 2018
Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1.
Journal: Scientific reports
Published: October 25, 2017
Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.
Journal: Virus genes
Published: December 05, 2016
Asna1/TRC40 that mediates membrane insertion of tail-anchored proteins is required for efficient release of Herpes simplex virus 1 virions.
Journal: Virology journal
Published: July 25, 2016
Last Updated: 09/26/2026